BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 27306643)

  • 1. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.
    O'Neill AF; Nguyen EM; Maldonado ED; Chang MR; Sun J; Zhu Q; Marasco WA
    Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelically and Differentially Expressed Genes After Infection of Edwardsiella ictaluri in Channel Catfish as Determined by Bulk Segregant RNA-Seq.
    Jin Y; Zhou T; Jiang W; Li N; Xu X; Tan S; Shi H; Yang Y; Yuan Z; Wang W; Qin G; Liu S; Gao D; Dunham R; Liu Z
    Mar Biotechnol (NY); 2022 Mar; 24(1):174-189. PubMed ID: 35166964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
    Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
    Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviation of Ultraviolet-B Radiation-Induced Photoaging by a TNFR Antagonistic Peptide, TNFR2-SKE.
    Lee KJ; Park KH; Hahn JH
    Mol Cells; 2019 Feb; 42(2):151-160. PubMed ID: 30703869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired Ig-Like Type 2 Receptor-Derived Agonist Ligands Ameliorate Inflammatory Reactions by Downregulating β1 Integrin Activity.
    Lee KJ; Lim D; Yoo YH; Park EJ; Lee SH; Yadav BK; Lee YK; Park JH; Kim D; Park KH; Hahn JH
    Mol Cells; 2016 Jul; 39(7):557-65. PubMed ID: 27306643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway.
    Lee KJ; Kim Y; Yoo YH; Kim MS; Lee SH; Kim CG; Park K; Jeoung D; Lee H; Ko IY; Hahn JH
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical characterization of O-glycosylated CD99 recognition by paired Ig-like type 2 receptors.
    Tabata S; Kuroki K; Wang J; Kajikawa M; Shiratori I; Kohda D; Arase H; Maenaka K
    J Biol Chem; 2008 Apr; 283(14):8893-901. PubMed ID: 18234675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR).
    Wang J; Shiratori I; Satoh T; Lanier LL; Arase H
    J Immunol; 2008 Feb; 180(3):1686-93. PubMed ID: 18209065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood flow guides sequential support of neutrophil arrest and diapedesis by PILR-β1 and PILR-α.
    Li YT; Goswami D; Follmer M; Artz A; Pacheco-Blanco M; Vestweber D
    Elife; 2019 Aug; 8():. PubMed ID: 31385804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor.
    Shiratori I; Ogasawara K; Saito T; Lanier LL; Arase H
    J Exp Med; 2004 Feb; 199(4):525-33. PubMed ID: 14970179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα.
    Kohyama M; Matsuoka S; Shida K; Sugihara F; Aoshi T; Kishida K; Ishii KJ; Arase H
    Eur J Immunol; 2016 May; 46(5):1214-23. PubMed ID: 26840635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
    Winger RC; Harp CT; Chiang MY; Sullivan DP; Watson RL; Weber EW; Podojil JR; Miller SD; Muller WA
    J Immunol; 2016 Feb; 196(4):1443-8. PubMed ID: 26773145
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.